chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Poor peripheral circulation, Skin discolouration
Clinical narrative: Poor blood circulation in leg and feet; Bottom of feet turn pinkish color then turn purple; Very pain full and swallowing at the bottom of foot; Very pain full and swallowing at the bottom of foot; Very cold feet; Unrecognizable symptoms of chill; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 18Mar2021 at 13:15 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the right arm on 25Feb2021 at 13:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 15Apr2021 at 00:00, after vaccine the patient had poor blood circulation in her leg and feet. Her bottom of feet turned pinkish color then turn purple, very pain full and "swallowing" at the bottom of foot. She had very cold feet and unrecognizable symptoms of chill. On an unknown date in 2021, the patient underwent blood test and the result was unknown. The events resulted in doctor/other health care professional office/clinic visit. Therapeutic measures were taken as a result of the events included "so many" blood test (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events poor blood circulation in leg and feet, bottom of feet turns pinkish color then turn purple, very pain full and swallowing at the bottom of foot, very cold feet and unrecognizable symptoms of chill was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Sex: M
Vaccine: COVID19
Symptoms: Arterial occlusive disease, Myocardial infarction
Clinical narrative: He is undergoing stent placement today as a result of an MI; clogged arteries; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported for a male patient (brother-in-law). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single and received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single both for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient was undergoing stent placement today as a result of an MI and had clogged arteries. The patient was undergoing stent placement today as a result of an MI. He also received both doses of the vaccine, but reporter did not have dates, lot numbers, or his age. The reporter just stated that he was a little bit older than her, and that it does not run in his family. The reporter complained that the covid shot was not a vaccine. If anything, it not only clogged the reporters arteries, but also her brother in law's. The reporter believed the ingredients in the vaccine cause blockages. The reporter asked if the ingredients could have caused her heart attack and if they've been the same all along. Therapeutic measures were taken as a result of the events. The outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation, Jaw disorder, Off label use, SARS-CoV-2 test, Tooth disorder
Clinical narrative: issues with "my" teeth; issues with "my" jaw; Booster dose taken before 22Sep2021; Booster dose taken before 22Sep2021; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received third (BOOSTER) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FO8448) via an unspecified route of administration in the left arm on 09Sep2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient had any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 (at the age of 56-years-old) and first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 08Oct2021, the patient experienced to have issues with her jaw and teeth. After she had spoken to others, it was reported that they were experiencing the same issues, and the patient queried "why was this?" (as reported) and wanted someone to call her. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and the patient was about to see a dentist. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent Nasal Swab, SARS CoV-2 test and the result was negative. The clinical outcome of the events issues with jaw and teeth were not resolved at the time of this report.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: Constant joint pain in right arm; mild pain in right arm; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 17May2021 (at the age of 50-year-old), as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 17Apr2021, as a single dose for COVID-19 immunisation. On 23Jun2021, the patient experienced constant joint pain in right arm and mild pain in right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event constant joint pain in right arm and mild pain in right arm was not resolved at the time of this report.
Sex: M
Vaccine: COVID19
Symptoms: Drug ineffective, Dyspnoea, Pneumonia, Suspected COVID-19
Clinical narrative: 'infected' COVID; 'infected' COVID; Pneumonia; Having difficulty breathing; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 59-year-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (lot number unknown, expiry date unknown) as DOSE 2, SINLGE, dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's height and weight was unknown. Patient's family number stated that the patient was infected with COVID-19 after fully vaccinated Pfizer vaccines on an unspecified date. Then the patient was hospitalized on 16Oct2021 for 5 days (till 21Oct2021). The patient experienced with pneumonia and felt difficulty to breath on an unspecified date. Outcome for all the events was unknown. Therapeutic measures were taken for all events. (oxygen put for difficulty breathing and other medication was performed)  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Immunisation, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Redness, slightly distal (`2in)to site of injection.; swelling slightly distal (`2in) to site of injection; Booster dose taken on 27Oct2021; This is a spontaneous report from a contactable nurse. A 26-year-old non-pregnant female patient received third (BOOSTER) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an intramuscular route of administration in the left arm on 27Oct2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to non-steroidal anti inflammatory drugs (NSAIDS). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date and also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 30Oct2021, the patient experienced redness and swelling slightly distal to 2 inches to the site of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events redness and swelling slightly distal to 2 inches to the site of injection were resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: got the 2 shots in Feb2021, was known to have gotten covid-19; got the 2 shots in Feb2021, was known to have gotten covid-19; This is a spontaneous report from a Pfizer. A contactable consumer reported for an 88-year-old female patient received bnt162b2 (COMIRNATY, lot unknown), via an unspecified route of administration on Feb2021 as DOSE 1,  SINGLE; received bnt162b2 (COMIRNATY, lot unknown) via an unspecified route of administration on Feb2021 as DOSE 2, SINGLE for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient had 2 shots in Feb2021 and was known to have gotten Covid-19 on unspecified date in 2021. The outcome of event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Chills, Pain, Pyrexia
Clinical narrative: Fever/chills; Fever/chills; Body aches; Arm pain from injection; Loss of smell & taste; Loss of smell & taste; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2593) via an unspecified route of administration in the left arm on 28Oct2021 at 10:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration in the left arm on 07Oct2021 at 10:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 28Oct2021, within 12 hours after second dose, the patient experienced fever/chills, body aches and arm pain from injection. On an unknown date in Oct2021, within 48 hours after second dose, the patient experienced loss of smell and taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever/chills, body aches, arm pain from injection and loss of smell and taste was not resolved at the time of this report.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Fever/chills; Fever/chills; Body aches; Arm pain from injection; Loss of smell & taste; Loss of smell & taste; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2593) via an unspecified route of administration in the left arm on 28Oct2021 at 10:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration in the left arm on 07Oct2021 at 10:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 28Oct2021, within 12 hours after second dose, the patient experienced fever/chills, body aches and arm pain from injection. On an unknown date in Oct2021, within 48 hours after second dose, the patient experienced loss of smell and taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever/chills, body aches, arm pain from injection and loss of smell and taste was not resolved at the time of this report.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Immunisation, Musculoskeletal stiffness
Clinical narrative: Significant joint pain in entire body (Not Day 0, Day 1-3) Moderate joint pain continues on Day 4; Significant joint pain and stiffness in entire body (Not Day 0, Day 1-3); Headache on day 1; Booster dose; This is a spontaneous report from a contactable healthcare professional, the patient. A 49-year-old non-pregnant female patient received third dose (booster) of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an intramuscular route of administration in the left arm on 28Oct2021 at 14:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimotos thyroiditis and allergy to sulfa containing medications. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an intramuscular route of administration in the left arm on 25Mar2021 (at the age of 48-years-old) and second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0169) via an intramuscular route of administration in the left arm on 22Apr2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation.  On 29Oct2021, the patient experienced significant joint pain and stiffness in entire body (Not Day 0, Day 1-3), moderate joint pain continued on Day 4 and headache on day 1. The events did not result in doctor or other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and significant joint pain was resolving, while that of the event stiffness in entire body was resolved on 31Oct2021.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Dizziness, Eye pain, Headache
Clinical narrative: Headache; Chills; Sweatiness; Body aches; Dizziness; Nausea; Eye pain; Anxiety; Racing heart; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 32030BD) via an unspecified route of administration in the left arm on 31Oct2021 at 14:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and mast cell activation syndrome (MCAS) and the patient was allergic to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lisinopril (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN), all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received influenza vaccine (flu vaccine) (MANUFACTURER UNKNOWN) for immunisation and experienced allergy to vaccine. On 31Oct2021 at 14:45, the patient experienced headache, chills, sweatiness, body aches, dizziness, nausea, eye pain, anxiety and racing heart. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, sweatiness, body aches, dizziness, nausea, eye pain, anxiety and racing heart were not resolved at the time of this report.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Nausea, Pain, Palpitations
Clinical narrative: Headache; Chills; Sweatiness; Body aches; Dizziness; Nausea; Eye pain; Anxiety; Racing heart; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 32030BD) via an unspecified route of administration in the left arm on 31Oct2021 at 14:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and mast cell activation syndrome (MCAS) and the patient was allergic to eggs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC), lisinopril (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN), all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received influenza vaccine (flu vaccine) (MANUFACTURER UNKNOWN) for immunisation and experienced allergy to vaccine. On 31Oct2021 at 14:45, the patient experienced headache, chills, sweatiness, body aches, dizziness, nausea, eye pain, anxiety and racing heart. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, sweatiness, body aches, dizziness, nausea, eye pain, anxiety and racing heart were not resolved at the time of this report.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: Tiredness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD0809) via an unspecified route of administration on 01Nov2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to trees flowering, apples and honey. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301558A) via an unspecified route of administration on 11Oct2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 01Nov2021, the patient experienced tiredness and headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness and headache was unknown at the time of the report.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Immunisation, Myalgia
Clinical narrative: Muscle aches; Chills; Fatigue; Headache; A third (booster) dose of BNT162b2 was administered; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3590) via an unspecified route of administration in the left arm on 24Oct2021 at 15:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CL3302) via an unspecified route of administration in the left arm on 11Feb2021 at 11:00 (at the age of 61-years-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Oct2021 at 02:30, the patient experienced muscle aches, chills, fatigue and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 28Oct2021, the patient underwent antigen test via nasal swab and the result was negative. The clinical outcome of the events muscle aches, chills, fatigue and headache were resolved on an unknown date in 2021.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Muscle aches; Chills; Fatigue; Headache; A third (booster) dose of BNT162b2 was administered; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3590) via an unspecified route of administration in the left arm on 24Oct2021 at 15:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: CL3302) via an unspecified route of administration in the left arm on 11Feb2021 at 11:00 (at the age of 61-years-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 11:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Oct2021 at 02:30, the patient experienced muscle aches, chills, fatigue and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 28Oct2021, the patient underwent antigen test via nasal swab and the result was negative. The clinical outcome of the events muscle aches, chills, fatigue and headache were resolved on an unknown date in 2021.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer or non-HCP (patient herself). A female patient, of an unspecified age, received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# unknown), via an unspecified route of administration, on Feb 18, 2021, single dose, for COVID-19 immunization. Medical history and concomitant medications not reported. On Feb 18, 2021, patient developed pain in her arm (possibly muscle pain). Reportedly, it has been 8 days since she received her vaccination, but the pain was still there. The pain was not exactly in the site of administration but down the arm. She wanted to know if this was normal. At the time of this report, the outcome of events: not recovered. No follow-up attempts possible. Information about batch/lot number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Coordination abnormal, Gait disturbance, Limb discomfort, Muscular weakness
Clinical narrative: her left leg is uncoordinated; very weak; wobbly, She is "able to walk but have to think about it"; no pain but heavy; LOST STRENGTH; This is a spontaneous report from a contactable consumer via medical information team.   This consumer reported for a 29-year-old female patient (consumer's daughter) that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number was not reported, Expiry date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced left leg is uncoordinated, very weak, wobbly, lost strength, no pain but heavy and able to walk but have to think about it. Patient has an appointment to see the doctor, but caller wanted to know if that was been reported. Th outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Dysuria, Hypoaesthesia, Muscle spasms
Clinical narrative: Numbness; Lot of pain in both calves used to call it charley horses; Drinking nothing and urinating non-stop every 10 minutes; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on 24Feb2021 at 02:10 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The medical history and concomitant medications were not reported. On 24Feb2021 the patient experienced numbness, lot of pain in both calves used to call it charley horses and drinking nothing and urinating non-stop every 10 minutes. It was reported that the patient went to get the shot (Pfizer, Covid-19 vaccine) yesterday for vaccination and last night my around, 7 and start getting numbness and this is in both calves lot of pain in both calves. The patient's wife described like years ago they used to call it charley horses but it never let out but had it about 2 hours on one and about same in the other, then started urinating and its non-stop and still continuing to about an hour ago, non-stop, the patient was drinking nothing and nothing following in prostate. The patient said that hopefully it still the same until now but non-stop every 10 minutes and was in the little mens room and its continue. The patient asked if theres something in the shot that makes urinate that much. The patient would wake up once in the evening once and in sleeping in the other next 8 hours last night it was continue, its kind of gradually fading about little bit and control about an hour ago and then it started again and stated that already made decision and not going for second dose. The outcome of the event drinking nothing and urinating non-stop every 10 minutes was not resolved for rest of the events the outcome was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Condition aggravated, Pain in extremity
Clinical narrative: leg and back pain began it has gotten worse; her back hurt; her arm was a little sore; her legs hurt; This is a spontaneous report from a contactable Consumer. This consumer reported for an 83 year-old female patient (Mother). An 83-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: EN6202) via unknown route of administration on 24Feb2021 01:00 (at the age of 83 years old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medication were not reported. On 24Feb2021 patient experienced her legs hurt, On 25Feb2021 her back hurt, her arm was a little sore and on an unspecified date leg and back pain began it has gotten worse. It was reported that She took her mother yesterday to get the shot at about 1 PM and then last night she said that her legs hurt, her arm didn't hurt but she woke up this morning her legs and her back hurt, her arm where she got shot a but that is little normal but then someone sent her this stuff where 30% of people have muscle pain. Her mom is just older and she wanted to check and see if she should give Aspirin or look for anything in particular. She has waited 45 minutes, the person who took the call should have been able to tell her that, she told them exactly what was going on. Her mom the got the first dose of the vaccine 24Feb2021. the leg pain started last night but then got worse today and then this morning her legs and back hurt and she had trouble getting out of bed. Her arm a little sore this morning. She confirms since the leg and back pain began it has gotten worse. The outcome of the events her legs and back hurt was not recovered and other was unknown.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Muscle spasms, Myalgia
Clinical narrative: having muscle spasms in the leg and left arm about 1.5 hours after the second dose; weakness; muscle pain; This is a spontaneous report from a contactable consumer (herself). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6198; Expiration Date: 30Jun2021), dose 2 via an unspecified route of administration, administered in Arm Right on an unspecified date as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN9581; Expiration Date: 31May2021), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced having muscle spasms in the leg and left arm about 1.5 hours after the second dose, weakness and muscle pain on an unspecified date. Caller stated that she received both doses of the Pfizer covid 19 vaccine. Caller stated she did fine after the first dose but started having muscle spasms in the leg and left arm about 1.5 hours after the second dose. Caller stated she got the vaccine in the right arm. Caller stated she continued to have muscle pain, weakness and spasms. Caller wanted to know if these were normal side effects. Caller stated she reported AE to safety already. Possible duplicate AE. Consumer also stated, she had been having some muscle pain and weakness and stuff like muscle spasms ever since she took her last vaccine. And she just wanted to find out was that some of the side effects. No therapeutic measures taken as a of result events. The clinical outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This is a spontaneous report from Pfizer-sponsored program from a contactable consumer via Medical Information Team. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. Patient had historical vaccine of first dose of bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number and Expiration date was unknown) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. She states she did not have any side effects but on 07Mar2021, the patient experienced headache and wants to take Excedrin. She wants to know if this is ok or will it affect the vaccine. The clinical outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: She has a slight headache; This is a spontaneous report from a Pfizer-sponsored program Pfizer  A 68-years-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient stated she has a slight headache on an unspecified date and to get rid of it she would like to take ibuprofen. At the time of reporting, the outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm hurt so much; This is a spontaneous report from a contactable other healthcare professional(patient). A 45-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, batch/lot number was not reported), via an unspecified route, administered in arm left on 13Feb2021 16:00 (at the age of 44-years-old) as dose 1, single for covid-19 immunization. Patient medical history included gastritis from an unknown date and unknown if ongoing. Concomitant medication included estradiol taken for an unspecified indication, start and stop date were not reported. The patient was not pregnant at time of vaccination. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date in 2021, the patient arm was hurted so much. The patient received acetaminophen and Alka-Seltzer as a treatment. The outcome of event was recovering.   Follow-up attempts are completed. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dehydration, Dizziness, Headache, Joint stiffness
Clinical narrative: stiffer; He states that he was only able to sleep 2 hours after; weak; soreness; dizziness; dehydration; Pain injection site; headache; stiffness in his joints; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 55-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution of injection, Lot Number: EN6204), via an unspecified route of administration, administered in Arm Left on 06Mar2021 (at the age of 55 years old) as dose 1, single for COVID-19 immunization. The patient's medical history included Deep venous insufficiency and Male pattern baldness from an unknown date and unknown if ongoing. The patient's concomitant medication included Celebrex (CELECOXIB), acetaminophen, vitamin C, and Vitamin D. The reporter reported that the patient stopped taking them 2 days prior to the vaccine. The patient had not received anything prior to the vaccine. On an unspecified date the patient experienced stiffer, he states that he was only able to sleep 2 hours after, weak, soreness, dizziness and dehydration while on 06Mar2021 the patient experienced stiffness in his joints, headache, Pain injection site. The patient reported that feeling the stiffness in joints, specifically ankles, knees, and hand. Patient stated that patient was only able to sleep 2 hours after, reporting feeling a little weak and everything. The next day the patient reported taking a 3 hours nap and feeling a little bit better after but still feeling very, very stiff in his shoulder to where he could not lift his arm. patient reported that this stiffness improved with some stretching and went away. The reporter reported that patient initially experienced pain with touch at the injection site but reports that that has now gone away as well. Patient also complains of stiffness in his neck and a headache between the temple region and the earlobe on the left side which Patient said feels like pain or soreness, feels like a stroke. Patient reported that this headache has now moved to the opposite side of his head, the right side and that it will go away when patient rest my head. Patient reported feeling dehydrated and states that patient felt better when the patient laid down. Patient reported that except for the stiffness, these symptoms were pretty mild. Patient reported that the patient normally takes a couple thousand mg of omega-3 fish oils and a shot 3 to 4 times a day of extra virgin olive oil to act as blood thinners. Facility of vaccine administration: Patient reported that it was also at the sae place at (institute name) in (address), the same place where he see's his PCP. It was suppose to be in Clinic A but patient had injection in Doctor (name withheld) office, which also calmed him down and took away his anxiety, because the place in line was to step into the office. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain, Sleep disorder, Vaccination site pain
Clinical narrative: stiffer; He states that he was only able to sleep 2 hours after; weak; soreness; dizziness; dehydration; Pain injection site; headache; stiffness in his joints; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 55-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution of injection, Lot Number: EN6204), via an unspecified route of administration, administered in Arm Left on 06Mar2021 (at the age of 55 years old) as dose 1, single for COVID-19 immunization. The patient's medical history included Deep venous insufficiency and Male pattern baldness from an unknown date and unknown if ongoing. The patient's concomitant medication included Celebrex (CELECOXIB), acetaminophen, vitamin C, and Vitamin D. The reporter reported that the patient stopped taking them 2 days prior to the vaccine. The patient had not received anything prior to the vaccine. On an unspecified date the patient experienced stiffer, he states that he was only able to sleep 2 hours after, weak, soreness, dizziness and dehydration while on 06Mar2021 the patient experienced stiffness in his joints, headache, Pain injection site. The patient reported that feeling the stiffness in joints, specifically ankles, knees, and hand. Patient stated that patient was only able to sleep 2 hours after, reporting feeling a little weak and everything. The next day the patient reported taking a 3 hours nap and feeling a little bit better after but still feeling very, very stiff in his shoulder to where he could not lift his arm. patient reported that this stiffness improved with some stretching and went away. The reporter reported that patient initially experienced pain with touch at the injection site but reports that that has now gone away as well. Patient also complains of stiffness in his neck and a headache between the temple region and the earlobe on the left side which Patient said feels like pain or soreness, feels like a stroke. Patient reported that this headache has now moved to the opposite side of his head, the right side and that it will go away when patient rest my head. Patient reported feeling dehydrated and states that patient felt better when the patient laid down. Patient reported that except for the stiffness, these symptoms were pretty mild. Patient reported that the patient normally takes a couple thousand mg of omega-3 fish oils and a shot 3 to 4 times a day of extra virgin olive oil to act as blood thinners. Facility of vaccine administration: Patient reported that it was also at the sae place at (institute name) in (address), the same place where he see's his PCP. It was suppose to be in Clinic A but patient had injection in Doctor (name withheld) office, which also calmed him down and took away his anxiety, because the place in line was to step into the office. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Glycosylated haemoglobin increased, Headache, Myalgia, Productive cough
Clinical narrative: experienced dizziness; feel headache; muscle pain in his back; cough too much, it was white mucus; This is a spontaneous report from a contactable consumer (patient).  A 54-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6200 and expiry date: not reported), via an unknown route of administration on 24Feb2021, as dose 1, single (Age at vaccination: 54-year-old) for COVID-19 immunization. Medical history information included: The patient had COVID-19 on 26Jan2021 with very mild symptoms. The patient was losing the senses such as loss of smell. He got well after 3 or 4 days and went back doing activity and also had ongoing Diabetes Type II. Concomitant medications included: Ongoing Metformin extended release at 500 mg, twice a day (morning/evening) for type 2 diabetes mellitus and it was controlled. The patient had the first dose of COVID-19 vaccine on 24Feb2021 by 4 o' clock or 4:15 afternoon and had some symptoms, the patient had dizziness after 2 mins of getting the vaccine. The patient was given some 'Motrin' (not clarified) and some stuff, and he left after like an hour because before that he could not drive. The patient went back to house, 3-4 hours later had headache and muscle pain in his back and hurtled him on left side and can't move for 2-3 days as it was really painful. The patient had been like 12 days for some symptoms, and I do know that happened to me because I had or I have too much antibodies. The patient stated that, it was the feeling like when somebody pulls the arm strongly, like some kind of, and cannot turn around and back was like really painful. It went like that for 24 hours and patient started using some Voltaren and took a pill of Feldene in home, of course made by Pfizer. The patient noticed them as like inflammatory pills, so he took one Feldene 20 mg at bedtime. It was so helpful. It was having some kind of inflammatory, muscle pain and also was hard for him 'doing the COVID-19 to tell' (not clarified). 3 or 4 days later started feeling cough, cough was with mucus, was white but strong. The patient laboratory tests included: A1C test was 6.5 on an unspecified date, and Covid 19 tested positive on 26Jan2021. Outcome of dizziness was recovered on 24Feb2021. Outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: experienced dizziness; feel headache; muscle pain in his back; cough too much, it was white mucus; This is a spontaneous report from a contactable consumer (patient).  A 54-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6200 and expiry date: not reported), via an unknown route of administration on 24Feb2021, as dose 1, single (Age at vaccination: 54-year-old) for COVID-19 immunization. Medical history information included: The patient had COVID-19 on 26Jan2021 with very mild symptoms. The patient was losing the senses such as loss of smell. He got well after 3 or 4 days and went back doing activity and also had ongoing Diabetes Type II. Concomitant medications included: Ongoing Metformin extended release at 500 mg, twice a day (morning/evening) for type 2 diabetes mellitus and it was controlled. The patient had the first dose of COVID-19 vaccine on 24Feb2021 by 4 o' clock or 4:15 afternoon and had some symptoms, the patient had dizziness after 2 mins of getting the vaccine. The patient was given some 'Motrin' (not clarified) and some stuff, and he left after like an hour because before that he could not drive. The patient went back to house, 3-4 hours later had headache and muscle pain in his back and hurtled him on left side and can't move for 2-3 days as it was really painful. The patient had been like 12 days for some symptoms, and I do know that happened to me because I had or I have too much antibodies. The patient stated that, it was the feeling like when somebody pulls the arm strongly, like some kind of, and cannot turn around and back was like really painful. It went like that for 24 hours and patient started using some Voltaren and took a pill of Feldene in home, of course made by Pfizer. The patient noticed them as like inflammatory pills, so he took one Feldene 20 mg at bedtime. It was so helpful. It was having some kind of inflammatory, muscle pain and also was hard for him 'doing the COVID-19 to tell' (not clarified). 3 or 4 days later started feeling cough, cough was with mucus, was white but strong. The patient laboratory tests included: A1C test was 6.5 on an unspecified date, and Covid 19 tested positive on 26Jan2021. Outcome of dizziness was recovered on 24Feb2021. Outcome of other events was unknown.  No follow-up attempts are possible. No further information is expected.